+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Next Generation Sequencing Market - Global Forecast 2026-2032- Product Image
Next Generation Sequencing Market - Global Forecast 2026-2032- Product Image
Sale

Next Generation Sequencing Market - Global Forecast 2026-2032

  • Report

  • 196 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 4968842
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Next Generation Sequencing Market is projected to reach USD 14.75 Billion in 2026. It is expected to continue growing at a CAGR of 16.72%, reaching USD 37.48 Billion by 2032.

Next generation sequencing has moved from a specialized research workflow into a core infrastructure layer for precision medicine, oncology, inherited disease testing, infectious disease surveillance, reproductive health, pharmacogenomics, agriculture, and biomanufacturing. The market is supported by verified advances in sequencing chemistry, library preparation, laboratory automation, and cloud-based bioinformatics that have reduced turnaround time while increasing throughput, scalability, and read accuracy.

Demand is strongest where NGS links directly to clinical utility, reimbursement readiness, drug development productivity, and public health value. Cancer profiling, rare disease diagnosis, liquid biopsy research, pathogen genomics, newborn screening research, and population-scale sequencing programs continue to expand adoption as laboratories seek scalable platforms that combine reliable data generation with validated interpretation and secure data management.

Transformative Shifts Reshaping Next Generation Sequencing

The NGS landscape is being reshaped by three structural shifts: the move from short-read dominance to a mixed short-read and long-read ecosystem, the migration of analysis from local servers to secure cloud and hybrid environments, and the integration of sequencing into routine clinical decision-making. High-throughput instruments now support population-scale projects, while benchtop and mid-throughput systems enable decentralized testing in hospital, regional, and specialty laboratories.

Long-read sequencing is gaining adoption for structural variants, repeat expansions, haplotype phasing, genome assembly, and metagenomics, while short-read platforms remain essential for cost-efficient oncology panels, exomes, transcriptomes, and high-volume sample processing. At the same time, regulatory-grade software, laboratory automation, sample-to-report workflows, interoperability, and quality management are becoming competitive differentiators as buyers prioritize reproducibility, compliance, and operational efficiency.

Cumulative Impact of Artificial Intelligence in NGS

Artificial intelligence is compounding the value of NGS by improving base calling, variant prioritization, annotation, quality control, and clinical interpretation. AI-enabled tools help reduce manual curation burden, identify sequencing artifacts, detect complex patterns in genomic and transcriptomic data, and accelerate the interpretation of large-scale genomic, epigenomic, and multiomic datasets.

The most significant impact is cumulative: each additional validated dataset can improve model performance, while each automated workflow can reduce turnaround time and cost per insight. In clinical environments, AI is particularly valuable for triaging variants of uncertain significance, linking genomic findings to phenotype data, supporting molecular tumor boards, and strengthening decision support. Governance remains critical, as algorithms must be validated, auditable, explainable where required, and aligned with privacy, cybersecurity, and medical-device requirements.

Key Regional Insights

North America remains a leading NGS region because of strong academic medical centers, advanced reference laboratory networks, biomedical funding, clinical trial activity, and broad adoption of oncology, rare disease, pharmacogenomics, and infectious disease sequencing. Europe benefits from national genomics strategies, mature biobank assets, cancer and rare disease programs, and regulation-led emphasis on data protection and clinical quality, with health-data initiatives expected to improve responsible cross-border data use over time.

Asia-Pacific is expanding as China, Japan, South Korea, India, Australia, and ASEAN economies invest in precision medicine, reproductive genomics, oncology testing, population genomics, and infectious disease surveillance. Latin America shows rising demand in Brazil and Mexico, supported by private diagnostics, academic collaborations, and expanding molecular laboratory capacity. The Middle East is advancing through national genome programs, preventive health strategies, and specialist hospital infrastructure, especially in Gulf countries, while Africa is building sequencing capacity through pathogen surveillance, human genomics initiatives, antimicrobial resistance monitoring, and regional research networks that improve genomic representation.

Key Group Insights

Among major economic and geopolitical groups, the G7 continues to lead in clinical adoption, reimbursement development, regulatory science, genomic medicine programs, and advanced sequencing infrastructure. The European Union is distinguished by coordinated health-data policy, genomics networks, rare disease collaboration, cancer mission priorities, and harmonized quality frameworks that support cross-country research and clinical implementation.

BRICS economies are increasingly important for high-volume sequencing demand, local manufacturing ambitions, biopharmaceutical research, and large-population genomic diversity. ASEAN markets are at varied stages, with Singapore and Thailand moving faster in clinical genomics and precision medicine adoption, while Indonesia, Vietnam, Malaysia, and the Philippines continue to expand laboratory capacity and workforce skills. GCC countries are investing in national genome initiatives, preventive medicine, population health, and specialized diagnostics, while NATO members benefit from strong biomedical research systems, biosecurity priorities, defense-related public health preparedness, and infectious disease surveillance capabilities.

Key Country Insights

The United States is a major NGS commercialization hub, supported by advanced diagnostics, biopharma demand, academic medicine, public health genomics, and large population research programs. Canada contributes through cancer genomics, newborn and rare disease initiatives, and publicly supported research networks, while Mexico and Brazil are strengthening private diagnostics, oncology testing access, and academic sequencing networks across Latin America.

In Europe, the United Kingdom, Germany, and France lead through national genomics programs, cancer strategies, rare disease frameworks, and industrial biotechnology capacity, while Italy and Spain are expanding hospital-based molecular testing and translational genomics. Russia maintains scientific capability in genomics and molecular biology but faces procurement, funding, and international collaboration constraints. In Asia-Pacific, China has substantial sequencing scale and population genomics activity, India is growing through affordability, disease diversity, and expanding diagnostic access, Japan and South Korea emphasize high-quality clinical adoption, oncology genomics, and advanced research infrastructure, and Australia supports genomics through public health programs, rare disease research, cancer genomics, and national research infrastructure.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize workflows that deliver measurable clinical, operational, or research outcomes rather than competing only on sequencing cost. Commercial success increasingly depends on end-to-end solutions that integrate sample preparation, sequencing, bioinformatics, reporting, data security, interoperability, quality assurance, and regulatory documentation.

Executives should build partnerships with hospitals, reference laboratories, biopharmaceutical developers, public health agencies, and national genomics programs to secure high-value use cases. Investment should focus on automation, AI-assisted interpretation, reimbursement evidence, decentralized testing support, workforce training, data governance, and compliance with evolving privacy, cybersecurity, and diagnostic regulations. Organizations that combine platform performance with trusted data interpretation, validated clinical evidence, and regionally adapted deployment models will be best positioned for durable growth.

Research Methodology

This executive summary is developed using secondary research from verified public sources, including regulatory agencies, national genomics programs, public health organizations, peer-reviewed literature, clinical guideline bodies, reimbursement references, government health-data initiatives, and published scientific collaborations. Market interpretation emphasizes documented technology adoption, policy direction, clinical use cases, regulatory context, and infrastructure investment.

The analysis applies a triangulated approach that compares platform trends, regional healthcare capacity, reimbursement maturity, research funding, regulatory readiness, laboratory infrastructure, and end-user demand across clinical diagnostics, pharmaceutical research, public health, agriculture, and academic genomics. Insights are synthesized to identify structural drivers, constraints, and strategic priorities without relying on unverified claims, market sizing, market share estimates, or unsupported projections.

Conclusion

Next generation sequencing is becoming a foundational technology for data-driven healthcare and life sciences. The market is no longer defined only by sequencing speed or cost; it is increasingly defined by the ability to convert genomic data into reliable, actionable, secure, and compliant decisions across clinical, research, public health, and industrial applications.

Adoption will be strongest where platforms, software, clinical evidence, reimbursement pathways, quality systems, and data governance align. As AI, long-read sequencing, multiomics, spatial biology, and population genomics mature, industry leaders that deliver validated workflows and regionally adapted strategies will be positioned to capture the highest-value opportunities in the global NGS ecosystem.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Next Generation Sequencing Market, by Offering
7.1. Introduction
7.2. Services
7.2.1. NGS-Based Testing Services
7.2.2. Library Preparation & Sequencing Services
7.2.3. Bioinformatics & Data Analysis Services
7.2.4. Support, Training & Qualification Services
7.2.5. Workflow & Assay Development Services
7.3. Consumables
7.3.1. Sequencing Reagents & Run Consumables
7.3.2. Library Preparation Kits
7.3.3. Target Enrichment & Assay Panels
7.4. Instruments & Workflow Systems
7.4.1. Sequencing Systems
7.4.2. Workflow Automation & Quality Control Systems
7.5. Software & Data Platforms
7.5.1. Secondary Analysis
7.5.2. Tertiary Analysis & Reporting
7.5.3. Data Management & Workflow Orchestration
7.5.4. Run Control & Primary Analysis
8. Next Generation Sequencing Market, by Sequencing Technology
8.1. Introduction
8.2. Reversible-Terminator Sequencing by Synthesis
8.3. Combinatorial Probe-Anchor Synthesis
8.4. Semiconductor Sequencing
8.5. Nanopore Sequencing
8.6. Single-Molecule Real-Time Sequencing
8.7. Flow-Based Sequencing by Synthesis
8.8. Avidity Sequencing
8.9. Antibody-Based Sequencing by Synthesis
8.10. Sequencing by Expansion
9. Next Generation Sequencing Market, by Read Modality
9.1. Introduction
9.2. Short Reads
9.2.1. Paired-End Short Reads
9.2.2. Single-End Short Reads
9.3. Long Reads
9.3.1. Single-Pass Long Reads
9.3.2. Consensus Long Reads
9.4. Hybrid Read Workflows
10. Next Generation Sequencing Market, by Assay Type
10.1. Introduction
10.2. Genomic DNA Sequencing
10.2.1. Targeted Gene & Region Sequencing
10.2.2. Whole Genome Sequencing
10.2.3. Whole Exome Sequencing
10.3. Transcriptome Sequencing
10.3.1. Whole Transcriptome & Messenger RNA Sequencing
10.3.2. Targeted RNA Sequencing
10.3.3. Small RNA Sequencing
10.4. Metagenomic & Microbial Community Sequencing
10.4.1. Shotgun Metagenomic Sequencing
10.4.2. Marker Gene Amplicon Sequencing
10.4.3. Metatranscriptomic Sequencing
10.5. Epigenome & Chromatin Sequencing
10.5.1. DNA Methylation Sequencing
10.5.2. Protein-DNA Interaction Sequencing
10.5.3. Chromatin Accessibility Sequencing
10.5.4. Chromatin Conformation Sequencing
10.6. Multiomic Sequencing
10.7. Immune Repertoire Sequencing
10.8. NGS-Readout Proteomic Assays
11. Next Generation Sequencing Market, by Assay Resolution
11.1. Introduction
11.2. Bulk & Pooled Sample Sequencing
11.3. Single-Cell Sequencing
11.4. Spatially Resolved Sequencing
11.5. Single-Nucleus Sequencing
12. Next Generation Sequencing Market, by Application
12.1. Introduction
12.2. Clinical Diagnostics & Patient Management
12.2.1. Oncology Testing
12.2.2. Inherited & Rare Disease Testing
12.2.3. Reproductive & Newborn Testing
12.2.4. Infectious Disease Testing
12.2.5. Pharmacogenomic Testing
12.2.6. Immune & Transplant Testing
12.3. Research & Discovery
12.3.1. Genome & Variant Discovery
12.3.2. Functional Genomics & Gene Regulation
12.3.3. Microbiome Research
12.3.4. Cell & Tissue Atlas Research
12.3.5. Comparative & Evolutionary Genomics
12.4. Biopharmaceutical Development
12.4.1. Target & Biomarker Discovery
12.4.2. Clinical Trial Stratification & Monitoring
12.4.3. Cell & Gene Therapy Characterization
12.4.4. Companion Diagnostic Development
12.4.5. Biologic Safety & Quality Testing
12.5. Agriculture & Animal Genomics
12.5.1. Crop & Livestock Breeding
12.5.2. Plant & Animal Health
12.6. Population & Consumer Genomics
12.6.1. Consumer Ancestry, Trait & Wellness Testing
12.6.2. Population Genomics & Screening
12.7. Public Health & Biosurveillance
12.7.1. Pathogen Surveillance & Outbreak Response
12.7.2. Antimicrobial Resistance Surveillance
12.8. Food & Environmental Genomics
12.8.1. Food Safety & Traceability
12.8.2. Environmental & Biodiversity Monitoring
12.9. Forensic & Identity Genomics
12.9.1. Human Identification & Kinship
12.9.2. Wildlife & Species Forensics
13. Next Generation Sequencing Market, by Buyer Type
13.1. Introduction
13.2. Healthcare & Diagnostic Organizations
13.2.1. Clinical & Molecular Diagnostic Laboratories
13.2.2. Hospitals & Health Systems
13.3. Biopharmaceutical Organizations
13.3.1. Pharmaceutical & Biotechnology Companies
13.3.2. Contract Research Organizations
13.4. Research Organizations
13.4.1. Academic & Research Institutes
13.4.2. Government Research Laboratories
13.5. Genomics Service Providers
13.5.1. Commercial Sequencing Service Providers
13.5.2. Genome Centers & Core Facilities
13.6. Public-Sector Testing Organizations
13.6.1. Public Health Laboratories
13.6.2. Forensic & Law-Enforcement Laboratories
13.7. Life Science Tools & Diagnostic Developers
13.8. Agriculture, Food & Environmental Organizations
13.8.1. Agricultural & Animal Health Organizations
13.8.2. Food Safety & Environmental Laboratories
13.9. Individual Consumers
14. Next Generation Sequencing Market, by Delivery Model
14.1. Introduction
14.2. Customer-Managed Deployment
14.2.1. Centralized Laboratory Deployment
14.2.2. Customer-Managed Informatics
14.2.2.1. On-Premises Informatics
14.2.2.2. Customer-Managed Cloud Informatics
14.2.3. Distributed & Point-of-Need Sequencing
14.3. Provider-Hosted & Outsourced Delivery
14.3.1. Outsourced Laboratory Services
14.3.1.1. Sample-to-Report Testing Services
14.3.1.2. Sequencing-to-Data Services
14.3.2. Hosted Informatics
14.3.2.1. Self-Service Vendor-Hosted Informatics
14.3.2.2. Managed Bioinformatics Services
14.4. Integrated Hybrid Deployment
15. Next Generation Sequencing Market, by Commercial Model
15.1. Introduction
15.2. Transactional Product Purchase
15.2.1. Consumables & Kit Purchase
15.2.2. Instrument & System Purchase
15.3. Fee-for-Service
15.3.1. Per-Sample & Per-Test Fees
15.3.2. Project-Based Fees
15.4. Subscription & Term Contract
15.4.1. Service & Support Contract
15.4.2. Software Subscription
15.5. Usage-Based Software Access
15.5.1. Pay-as-You-Go Usage
15.5.2. Committed Usage Plan
15.6. Lease & Placement
15.6.1. Reagent-Commitment Placement
15.6.2. Instrument Lease & Rental
15.7. Development & Licensing
15.7.1. Custom Development Agreement
15.7.2. Technology & Intellectual Property License
16. Next Generation Sequencing Market, by Intended Use Status
16.1. Introduction
16.2. Research Use Only
16.3. Regulator-Authorized In Vitro Diagnostic Use
16.4. In-House Clinical Laboratory Use
16.5. Investigational & Performance-Study Use
16.6. Validated Non-Clinical Laboratory Use
17. Next Generation Sequencing Market, by Region
17.1. Introduction
17.2. Europe
17.3. Asia-Pacific
17.4. North America
17.5. Latin America
17.6. Middle East
17.7. Africa
18. Next Generation Sequencing Market, by Group
18.1. Introduction
18.2. NATO
18.3. G7
18.4. European Union
18.5. BRICS
18.6. ASEAN
18.7. GCC
19. Next Generation Sequencing Market, by Country
19.1. Introduction
19.2. United States
19.3. China
19.4. Germany
19.5. Japan
19.6. India
19.7. United Kingdom
19.8. France
19.9. South Korea
19.10. Canada
19.11. Italy
19.12. Australia
19.13. Brazil
19.14. Spain
19.15. Russia
19.16. Mexico
20. Competitive Landscape
20.1. Market Share Analysis, 2025
20.2. Market Concentration Analysis, 2025
20.2.1. Concentration Ratio (CR)
20.2.2. Herfindahl Hirschman Index (HHI)
20.3. Recent Developments & Impact Analysis, 2025
20.4. Product Portfolio Analysis, 2025
20.5. Benchmarking Analysis, 2025
21. Company Profiles
21.1. Illumina, Inc.
21.2. Thermo Fisher Scientific Inc.
21.3. Pacific Biosciences of California, Inc.
21.4. Oxford Nanopore Technologies plc
21.5. MGI Tech Co., Ltd.
21.6. Element Biosciences, Inc.
21.7. Ultima Genomics, Inc.
21.8. QIAGEN N.V.
21.9. Agilent Technologies, Inc.
21.10. F. Hoffmann-La Roche Ltd
21.11. Twist Bioscience Corporation
21.12. New England Biolabs, Inc.
21.13. Integrated DNA Technologies, Inc.
21.14. Revvity, Inc.
21.15. Takara Bio Inc.
21.16. BGI Genomics Co., Ltd.
21.17. Azenta Life Sciences
21.18. Novogene Co., Ltd.
21.19. Eurofins Genomics LLC
21.20. Macrogen, Inc.
21.21. GeneMind Biosciences Company Limited
21.22. Annoroad Gene Technology (Beijing) Co., Ltd.
21.23. Biomarker Technologies (BMKGENE)
21.24. Qitan Tech
21.25. Theragen Bio Co., Ltd.
21.26. Welgene Biotech Co., Ltd.
21.27. Genotypic Technology Pvt. Ltd.
21.28. Australian Genome Research Facility Ltd
21.29. CeGaT GmbH
21.30. Microsynth AG
21.31. GenomeScan B.V.
21.32. NimaGen B.V.
21.33. Inqaba Biotechnical Industries (Pty) Ltd
21.34. 10x Genomics, Inc.
21.35. Singular Genomics Systems, Inc.
21.36. Mission Bio
21.37. Singleron Biotechnologies
21.38. BioSkryb Genomics, Inc.
21.39. Watchmaker Genomics
21.40. Bruker Corporation
21.41. Beckman Coulter, Inc.
21.42. Volta Labs, Inc.
21.43. INTEGRA Biosciences AG
21.44. Daicel Arbor Biosciences
21.45. Waters Corporation
21.46. SOPHiA GENETICS SA
21.47. DNAnexus, Inc.
21.48. Sentieon, Inc.
21.49. Velsera Inc.
22. Key Experts
List of Figures
FIGURE 1. Global Next Generation Sequencing Market, Years Considered for the Study
FIGURE 2. Global Next Generation Sequencing Market, Research Design
FIGURE 3. Global Next Generation Sequencing Market, Research Framework
FIGURE 4. Global Next Generation Sequencing Market, Data Triangulation
FIGURE 5. Global Next Generation Sequencing Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Next Generation Sequencing Market Size, by Offering, 2025 vs 2032 (%)
FIGURE 7. Global Next Generation Sequencing Market Size, by Offering, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Next Generation Sequencing Market Size, by Sequencing Technology, 2025 vs 2032 (%)
FIGURE 9. Global Next Generation Sequencing Market Size, by Sequencing Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Next Generation Sequencing Market Size, by Read Modality, 2025 vs 2032 (%)
FIGURE 11. Global Next Generation Sequencing Market Size, by Read Modality, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Next Generation Sequencing Market Size, by Assay Type, 2025 vs 2032 (%)
FIGURE 13. Global Next Generation Sequencing Market Size, by Assay Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Next Generation Sequencing Market Size, by Assay Resolution, 2025 vs 2032 (%)
FIGURE 15. Global Next Generation Sequencing Market Size, by Assay Resolution, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Next Generation Sequencing Market Size, by Application, 2025 vs 2032 (%)
FIGURE 17. Global Next Generation Sequencing Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Next Generation Sequencing Market Size, by Buyer Type, 2025 vs 2032 (%)
FIGURE 19. Global Next Generation Sequencing Market Size, by Buyer Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Next Generation Sequencing Market Size, by Delivery Model, 2025 vs 2032 (%)
FIGURE 21. Global Next Generation Sequencing Market Size, by Delivery Model, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 22. Global Next Generation Sequencing Market Size, by Commercial Model, 2025 vs 2032 (%)
FIGURE 23. Global Next Generation Sequencing Market Size, by Commercial Model, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 24. Global Next Generation Sequencing Market Size, by Intended Use Status, 2025 vs 2032 (%)
FIGURE 25. Global Next Generation Sequencing Market Size, by Intended Use Status, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 26. Global Next Generation Sequencing Market Size, by Region, 2025 vs 2032 (%)
FIGURE 27. Global Next Generation Sequencing Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 28. Global Next Generation Sequencing Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 29. Global Next Generation Sequencing Market Size, by Country, 2025 vs 2032 (%)
FIGURE 30. Global Next Generation Sequencing Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 31. Global Next Generation Sequencing Market Share, by Key Player, 2025
List of Tables
TABLE 1. Global Next Generation Sequencing Market Segmentation & Coverage
TABLE 2. Global Next Generation Sequencing Market Size, 2017-2032 (USD Million)
TABLE 3. Global Next Generation Sequencing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 4. Global Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global NGS-Based Testing Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global NGS-Based Testing Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global NGS-Based Testing Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Library Preparation & Sequencing Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Library Preparation & Sequencing Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Library Preparation & Sequencing Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Bioinformatics & Data Analysis Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Bioinformatics & Data Analysis Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Bioinformatics & Data Analysis Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Support, Training & Qualification Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Support, Training & Qualification Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Support, Training & Qualification Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Workflow & Assay Development Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Workflow & Assay Development Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Workflow & Assay Development Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Consumables Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Consumables Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Consumables Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Sequencing Reagents & Run Consumables Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Sequencing Reagents & Run Consumables Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Sequencing Reagents & Run Consumables Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Library Preparation Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Library Preparation Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Library Preparation Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Target Enrichment & Assay Panels Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Target Enrichment & Assay Panels Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Target Enrichment & Assay Panels Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Instruments & Workflow Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Instruments & Workflow Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Instruments & Workflow Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Sequencing Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Sequencing Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Sequencing Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Workflow Automation & Quality Control Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Workflow Automation & Quality Control Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Workflow Automation & Quality Control Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Software & Data Platforms Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Software & Data Platforms Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Software & Data Platforms Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Secondary Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Secondary Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Secondary Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Tertiary Analysis & Reporting Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Tertiary Analysis & Reporting Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Tertiary Analysis & Reporting Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Data Management & Workflow Orchestration Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Data Management & Workflow Orchestration Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Data Management & Workflow Orchestration Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Run Control & Primary Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Run Control & Primary Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Run Control & Primary Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Next Generation Sequencing Market Size, by Sequencing Technology, 2017-2032 (USD Million)
TABLE 59. Global Reversible-Terminator Sequencing by Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Reversible-Terminator Sequencing by Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Reversible-Terminator Sequencing by Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Combinatorial Probe-Anchor Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Combinatorial Probe-Anchor Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Combinatorial Probe-Anchor Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Semiconductor Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Semiconductor Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Semiconductor Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Nanopore Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Nanopore Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Nanopore Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Single-Molecule Real-Time Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Single-Molecule Real-Time Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Single-Molecule Real-Time Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Flow-Based Sequencing by Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Flow-Based Sequencing by Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Flow-Based Sequencing by Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Avidity Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Avidity Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Avidity Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Antibody-Based Sequencing by Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Antibody-Based Sequencing by Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Antibody-Based Sequencing by Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Sequencing by Expansion Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Sequencing by Expansion Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Sequencing by Expansion Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Next Generation Sequencing Market Size, by Read Modality, 2017-2032 (USD Million)
TABLE 87. Global Short Reads Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Short Reads Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Short Reads Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Paired-End Short Reads Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Paired-End Short Reads Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Paired-End Short Reads Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Single-End Short Reads Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Single-End Short Reads Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Single-End Short Reads Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Long Reads Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Global Long Reads Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. Global Long Reads Market Size, by Country, 2017-2032 (USD Million)
TABLE 99. Global Single-Pass Long Reads Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Global Single-Pass Long Reads Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. Global Single-Pass Long Reads Market Size, by Country, 2017-2032 (USD Million)
TABLE 102. Global Consensus Long Reads Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Global Consensus Long Reads Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. Global Consensus Long Reads Market Size, by Country, 2017-2032 (USD Million)
TABLE 105. Global Hybrid Read Workflows Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Global Hybrid Read Workflows Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. Global Hybrid Read Workflows Market Size, by Country, 2017-2032 (USD Million)
TABLE 108. Global Next Generation Sequencing Market Size, by Assay Type, 2017-2032 (USD Million)
TABLE 109. Global Genomic DNA Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Genomic DNA Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Genomic DNA Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Targeted Gene & Region Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Targeted Gene & Region Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Targeted Gene & Region Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Whole Genome Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Global Whole Genome Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. Global Whole Genome Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 118. Global Whole Exome Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Global Whole Exome Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. Global Whole Exome Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 121. Global Transcriptome Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. Global Transcriptome Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. Global Transcriptome Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 124. Global Whole Transcriptome & Messenger RNA Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 125. Global Whole Transcriptome & Messenger RNA Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. Global Whole Transcriptome & Messenger RNA Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 127. Global Targeted RNA Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 128. Global Targeted RNA Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 129. Global Targeted RNA Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 130. Global Small RNA Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 131. Global Small RNA Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. Global Small RNA Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 133. Global Metagenomic & Microbial Community Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. Global Metagenomic & Microbial Community Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. Global Metagenomic & Microbial Community Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 136. Global Shotgun Metagenomic Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 137. Global Shotgun Metagenomic Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. Global Shotgun Metagenomic Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 139. Global Marker Gene Amplicon Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 140. Global Marker Gene Amplicon Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 141. Global Marker Gene Amplicon Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 142. Global Metatranscriptomic Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 143. Global Metatranscriptomic Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. Global Metatranscriptomic Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 145. Global Epigenome & Chromatin Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 146. Global Epigenome & Chromatin Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 147. Global Epigenome & Chromatin Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 148. Global DNA Methylation Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 149. Global DNA Methylation Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. Global DNA Methylation Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 151. Global Protein-DNA Interaction Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 152. Global Protein-DNA Interaction Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 153. Global Protein-DNA Interaction Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 154. Global Chromatin Accessibility Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 155. Global Chromatin Accessibility Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 156. Global Chromatin Accessibility Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 157. Global Chromatin Conformation Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 158. Global Chromatin Conformation Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 159. Global Chromatin Conformation Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 160. Global Multiomic Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 161. Global Multiomic Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 162. Global Multiomic Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 163. Global Immune Repertoire Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 164. Global Immune Repertoire Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 165. Global Immune Repertoire Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 166. Global NGS-Readout Proteomic Assays Market Size, by Region, 2017-2032 (USD Million)
TABLE 167. Global NGS-Readout Proteomic Assays Market Size, by Group, 2017-2032 (USD Million)
TABLE 168. Global NGS-Readout Proteomic Assays Market Size, by Country, 2017-2032 (USD Million)
TABLE 169. Global Next Generation Sequencing Market Size, by Assay Resolution, 2017-2032 (USD Million)
TABLE 170. Global Bulk & Pooled Sample Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 171. Global Bulk & Pooled Sample Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 172. Global Bulk & Pooled Sample Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 173. Global Single-Cell Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 174. Global Single-Cell Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 175. Global Single-Cell Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 176. Global Spatially Resolved Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 177. Global Spatially Resolved Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 178. Global Spatially Resolved Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 179. Global Single-Nucleus Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 180. Global Single-Nucleus Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 181. Global Single-Nucleus Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 182. Global Next Generation Sequencing Market Size, by Application, 2017-2032 (USD Million)
TABLE 183. Global Clinical Diagnostics & Patient Management Market Size, by Region, 2017-2032 (USD Million)
TABLE 184. Global Clinical Diagnostics & Patient Management Market Size, by Group, 2017-2032 (USD Million)
TABLE 185. Global Clinical Diagnostics & Patient Management Market Size, by Country, 2017-2032 (USD Million)
TABLE 186. Global Oncology Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 187. Global Oncology Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 188. Global Oncology Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 189. Global Inherited & Rare Disease Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 190. Global Inherited & Rare Disease Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 191. Global Inherited & Rare Disease Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 192. Global Reproductive & Newborn Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 193. Global Reproductive & Newborn Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 194. Global Reproductive & Newborn Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 195. Global Infectious Disease Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 196. Global Infectious Disease Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 197. Global Infectious Disease Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 198. Global Pharmacogenomic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 199. Global Pharmacogenomic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 200. Global Pharmacogenomic Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 201. Global Immune & Transplant Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 202. Global Immune & Transplant Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 203. Global Immune & Transplant Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 204. Global Research & Discovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 205. Global Research & Discovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 206. Global Research & Discovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 207. Global Genome & Variant Discovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 208. Global Genome & Variant Discovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 209. Global Genome & Variant Discovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 210. Global Functional Genomics & Gene Regulation Market Size, by Region, 2017-2032 (USD Million)
TABLE 211. Global Functional Genomics & Gene Regulation Market Size, by Group, 2017-2032 (USD Million)
TABLE 212. Global Functional Genomics & Gene Regulation Market Size, by Country, 2017-2032 (USD Million)
TABLE 213. Global Microbiome Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 214. Global Microbiome Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 215. Global Microbiome Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 216. Global Cell & Tissue Atlas Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 217. Global Cell & Tissue Atlas Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 218. Global Cell & Tissue Atlas Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 219. Global Comparative & Evolutionary Genomics Market Size, by Region, 2017-2032 (USD Million)
TABLE 220. Global Comparative & Evolutionary Genomics Market Size, by Group, 2017-2032 (USD Million)
TABLE 221. Global Comparative & Evolutionary Genomics Market Size, by Country, 2017-2032 (USD Million)
TABLE 222. Global Biopharmaceutical Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 223. Global Biopharmaceutical Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 224. Global Biopharmaceutical Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 225. Global Target & Biomarker Discovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 226. Global Target & Biomarker Discovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 227. Global Target & Biomarker Discovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 228. Global Clinical Trial Stratification & Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 229. Global Clinical Trial Stratification & Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 230. Global Clinical Trial Stratification & Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 231. Global Cell & Gene Therapy Characterization Market Size, by Region, 2017-2032 (USD Million)
TABLE 232. Global Cell & Gene Therapy Characterization Market Size, by Group, 2017-2032 (USD Million)
TABLE 233. Global Cell & Gene Therapy Characterization Market Size, by Country, 2017-2032 (USD Million)
TABLE 234. Global Companion Diagnostic Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 235. Global Companion Diagnostic Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 236. Global Companion Diagnostic Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 237. Global Biologic Safety & Quality Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 238. Global Biologic Safety & Quality Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 239. Global Biologic Safety & Quality Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 240. Global Agriculture & Animal Genomics Market Size, by Region, 2017-2032 (USD Million)
TABLE 241. Global Agriculture & Animal Genomics Market Size, by Group, 2017-2032 (USD Million)
TABLE 242. Global Agriculture & Animal Genomics Market Size, by Country, 2017-2032 (USD Million)
TABLE 243. Global Crop & Livestock Breeding Market Size, by Region, 2017-2032 (USD Million)
TABLE 244. Global Crop & Livestock Breeding Market Size, by Group, 2017-2032 (USD Million)
TABLE 245. Global Crop & Livestock Breeding Market Size, by Country, 2017-2032 (USD Million)
TABLE 246. Global Plant & Animal Health Market Size, by Region, 2017-2032 (USD Million)
TABLE 247. Global Plant & Animal Health Market Size, by Group, 2017-2032 (USD Million)
TABLE 248. Global Plant & Animal Health Market Size, by Country, 2017-2032 (USD Million)
TABLE 249. Global Population & Consumer Genomics Market Size, by Region, 2017-2032 (USD Million)
TABLE 250. Global Population & Consumer Genomics Market Size, by Group, 2017-2032 (USD Million)
TABLE 251. Global Population & Consumer Genomics Market Size, by Country, 2017-2032 (USD Million)
TABLE 252. Global Consumer Ancestry, Trait & Wellness Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 253. Global Consumer Ancestry, Trait & Wellness Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 254. Global Consumer Ancestry, Trait & Wellness Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 255. Global Population Genomics & Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 256. Global Population Genomics & Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 257. Global Population Genomics & Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 258. Global Public Health & Biosurveillance Market Size, by Region, 2017-2032 (USD Million)
TABLE 259. Global Public Health & Biosurveillance Market Size, by Group, 2017-2032 (USD Million)
TABLE 260. Global Public Health & Biosurveillance Market Size, by Country, 2017-2032 (USD Million)
TABLE 261. Global Pathogen Surveillance & Outbreak Response Market Size, by Region, 2017-2032 (USD Million)
TABLE 262. Global Pathogen Surveillance & Outbreak Response Market Size, by Group, 2017-2032 (USD Million)
TABLE 263. Global Pathogen Surveillance & Outbreak Response Market Size, by Country, 2017-2032 (USD Million)
TABLE 264. Global Antimicrobial Resistance Surveillance Market Size, by Region, 2017-2032 (USD Million)
TABLE 265. Global Antimicrobial Resistance Surveillance Market Size, by Group, 2017-2032 (USD Million)
TABLE 266. Global Antimicrobial Resistance Surveillance Market Size, by Country, 2017-2032 (USD Million)
TABLE 267. Global Food & Environmental Genomics Market Size, by Region, 2017-2032 (USD Million)
TABLE 268. Global Food & Environmental Genomics Market Size, by Group, 2017-2032 (USD Million)
TABLE 269. Global Food & Environmental Genomics Market Size, by Country, 2017-2032 (USD Million)
TABLE 270. Global Food Safety & Traceability Market Size, by Region, 2017-2032 (USD Million)
TABLE 271. Global Food Safety & Traceability Market Size, by Group, 2017-2032 (USD Million)
TABLE 272. Global Food Safety & Traceability Market Size, by Country, 2017-2032 (USD Million)
TABLE 273. Global Environmental & Biodiversity Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 274. Global Environmental & Biodiversity Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 275. Global Environmental & Biodiversity Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 276. Global Forensic & Identity Genomics Market Size, by Region, 2017-2032 (USD Million)
TABLE 277. Global Forensic & Identity Genomics Market Size, by Group, 2017-2032 (USD Million)
TABLE 278. Global Forensic & Identity Genomics Market Size, by Country, 2017-2032 (USD Million)
TABLE 279. Global Human Identification & Kinship Market Size, by Region, 2017-2032 (USD Million)
TABLE 280. Global Human Identification & Kinship Market Size, by Group, 2017-2032 (USD Million)
TABLE 281. Global Human Identification & Kinship Market Size, by Country, 2017-2032 (USD Million)
TABLE 282. Global Wildlife & Species Forensics Market Size, by Region, 2017-2032 (USD Million)
TABLE 283. Global Wildlife & Species Forensics Market Size, by Group, 2017-2032 (USD Million)
TABLE 284. Global Wildlife & Species Forensics Market Size, by Country, 2017-2032 (USD Million)
TABLE 285. Global Next Generation Sequencing Market Size, by Buyer Type, 2017-2032 (USD Million)
TABLE 286. Global Healthcare & Diagnostic Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 287. Global Healthcare & Diagnostic Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 288. Global Healthcare & Diagnostic Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 289. Global Clinical & Molecular Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 290. Global Clinical & Molecular Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 291. Global Clinical & Molecular Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 292. Global Hospitals & Health Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 293. Global Hospitals & Health Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 294. Global Hospitals & Health Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 295. Global Biopharmaceutical Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 296. Global Biopharmaceutical Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 297. Global Biopharmaceutical Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 298. Global Pharmaceutical & Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 299. Global Pharmaceutical & Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 300. Global Pharmaceutical & Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 301. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 302. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 303. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 304. Global Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 305. Global Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 306. Global Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 307. Global Academic & Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 308. Global Academic & Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 309. Global Academic & Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 310. Global Government Research Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 311. Global Government Research Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 312. Global Government Research Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 313. Global Genomics Service Providers Market Size, by Region, 2017-2032 (USD Million)
TABLE 314. Global Genomics Service Providers Market Size, by Group, 2017-2032 (USD Million)
TABLE 315. Global Genomics Service Providers Market Size, by Country, 2017-2032 (USD Million)
TABLE 316. Global Commercial Sequencing Service Providers Market Size, by Region, 2017-2032 (USD Million)
TABLE 317. Global Commercial Sequencing Service Providers Market Size, by Group, 2017-2032 (USD Million)
TABLE 318. Global Commercial Sequencing Service Providers Market Size, by Country, 2017-2032 (USD Million)
TABLE 319. Global Genome Centers & Core Facilities Market Size, by Region, 2017-2032 (USD Million)
TABLE 320. Global Genome Centers & Core Facilities Market Size, by Group, 2017-2032 (USD Million)
TABLE 321. Global Genome Centers & Core Facilities Market Size, by Country, 2017-2032 (USD Million)
TABLE 322. Global Public-Sector Testing Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 323. Global Public-Sector Testing Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 324. Global Public-Sector Testing Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 325. Global Public Health Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 326. Global Public Health Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 327. Global Public Health Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 328. Global Forensic & Law-Enforcement Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 329. Global Forensic & Law-Enforcement Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 330. Global Forensic & Law-Enforcement Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 331. Global Life Science Tools & Diagnostic Developers Market Size, by Region, 2017-2032 (USD Million)
TABLE 332. Global Life Science Tools & Diagnostic Developers Market Size, by Group, 2017-2032 (USD Million)
TABLE 333. Global Life Science Tools & Diagnostic Developers Market Size, by Country, 2017-2032 (USD Million)
TABLE 334. Global Agriculture, Food & Environmental Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 335. Global Agriculture, Food & Environmental Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 336. Global Agriculture, Food & Environmental Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 337. Global Agricultural & Animal Health Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 338. Global Agricultural & Animal Health Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 339. Global Agricultural & Animal Health Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 340. Global Food Safety & Environmental Laboratories Market Size, by Region, 2017-2032 (

Companies Mentioned

  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • Pacific Biosciences of California, Inc.
  • Oxford Nanopore Technologies plc
  • MGI Tech Co., Ltd.
  • Element Biosciences, Inc.
  • Ultima Genomics, Inc.
  • QIAGEN N.V.
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche Ltd
  • Twist Bioscience Corporation
  • New England Biolabs, Inc.
  • Integrated DNA Technologies, Inc.
  • Revvity, Inc.
  • Takara Bio Inc.
  • BGI Genomics Co., Ltd.
  • Azenta Life Sciences
  • Novogene Co., Ltd.
  • Eurofins Genomics LLC
  • Macrogen, Inc.
  • GeneMind Biosciences Company Limited
  • Annoroad Gene Technology (Beijing) Co., Ltd.
  • Biomarker Technologies (BMKGENE)
  • Qitan Tech
  • Theragen Bio Co., Ltd.
  • Welgene Biotech Co., Ltd.
  • Genotypic Technology Pvt. Ltd.
  • Australian Genome Research Facility Ltd
  • CeGaT GmbH
  • Microsynth AG
  • GenomeScan B.V.
  • NimaGen B.V.
  • Inqaba Biotechnical Industries (Pty) Ltd
  • 10x Genomics, Inc.
  • Singular Genomics Systems, Inc.
  • Mission Bio
  • Singleron Biotechnologies
  • BioSkryb Genomics, Inc.
  • Watchmaker Genomics
  • Bruker Corporation
  • Beckman Coulter, Inc.
  • Volta Labs, Inc.
  • INTEGRA Biosciences AG
  • Daicel Arbor Biosciences
  • Waters Corporation
  • SOPHiA GENETICS SA
  • DNAnexus, Inc.
  • Sentieon, Inc.
  • Velsera Inc.

Table Information

Report AttributeDetails
No. of Pages196
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 14.75 Billion
Forecasted Market Value ( USD ) by 2032 $ 37.48 Billion
Compound Annual Growth Rate16.7%
Regions CoveredGlobal
No. of Companies Mentioned49

Related Topics

Related Reports

Next-Generation Sequencing Data Analysis Market - Global Forecast 2026-2032 - Product Image

Next-Generation Sequencing Data Analysis Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Next-Generation Sequencing Sample Preparation Market - Global Forecast 2026-2032 - Product Image

Next-Generation Sequencing Sample Preparation Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Clinical Oncology Next Generation Sequencing - Global Strategic Business Report - Product Image

Clinical Oncology Next Generation Sequencing - Global Strategic Business Report

  • Report
  • 462 Pages
  • Global
From
Next Generation Sequencing - Market Insights, Competitive Landscape, and Market Forecast - 2034 - Product Image

Next Generation Sequencing - Market Insights, Competitive Landscape, and Market Forecast - 2034

  • Report
  • 150 Pages
  • Global
From
Next Generation Sequencing (NGS) Sample Preparation - Global Strategic Business Report - Product Image

Next Generation Sequencing (NGS) Sample Preparation - Global Strategic Business Report

  • Report
  • 206 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.